KAS
CRL icon

Kestra Advisory Services’s Charles River Laboratories CRL Stock Holding History

Kestra Advisory Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-545
Closed -$109K – 3373
2025
Q4 		$109K Buy
+545
New +$98.9K ﹤0.01% 3359
2025
Q2 		– Sell
-1,903
Closed -$286K – 2851
2025
Q1 		$286K Sell
1,903
-405
-18% -$67.9K ﹤0.01% 2196
2024
Q4 		$426K Sell
2,308
-893
-28% -$172K ﹤0.01% 1980
2024
Q3 		$631K Sell
3,201
-17
-0.5% -$3.53K ﹤0.01% 1620
2024
Q2 		$665K Buy
3,218
+12
+0.4% +$2.72K ﹤0.01% 1592
2024
Q1 		$869K Buy
3,206
+224
+8% +$53.5K 0.01% 1325
2023
Q4 		$705K Buy
2,982
+304
+11% +$59.8K 0.01% 1319
2023
Q3 		$525K Buy
2,678
+48
+2% +$9.85K 0.01% 1347
2023
Q2 		$553K Sell
2,630
-188
-7% -$37.4K 0.01% 1277
2023
Q1 		$569K Sell
2,818
-5,955
-68% -$1.35M 0.01% 1211
2022
Q4 		$1.91M Buy
8,773
+800
+10% +$175K 0.02% 768
2022
Q3 		$1.57M Sell
7,973
-405
-5% -$87.4K 0.02% 762
2022
Q2 		$1.79M Buy
8,378
+1,194
+17% +$292K 0.02% 715
2022
Q1 		$2.04M Buy
7,184
+1,096
+18% +$338K 0.02% 669
2021
Q4 		$2.29M Buy
6,088
+1,723
+39% +$669K 0.02% 637
2021
Q3 		$1.8M Buy
4,365
+157
+4% +$65.2K 0.02% 759
2021
Q2 		$1.56M Sell
4,208
-624
-13% -$208K 0.02% 749
2021
Q1 		$1.4M Buy
4,832
+3,832
+383% +$1.07M 0.02% 733
2020
Q4 		$249K Buy
+1,000
New +$238K ﹤0.01% 1574

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Kestra Advisory Services's CRL Position: Q1 2026 in Review

Kestra Advisory Services sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 545 shares — an estimated $109K sold.

Kestra Advisory Services first reported a position in CRL in Q4 2020 and held it in 19 quarters. The position peaked at $2.29M in Q4 2021. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Kestra Advisory Services reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Kestra Advisory Services sold 545 Charles River Laboratories shares in Q1 2026, an estimated $109K.
  • Kestra Advisory Services first reported a position in Charles River Laboratories in Q4 2020 and held it in 19 quarters.
  • Kestra Advisory Services's Charles River Laboratories position peaked at $2.29M in Q4 2021.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.